Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Results: Appen shares soar 9.2% as first-half sales hit $245 million

Appen’s 2019 interim results revealed expanding margins, surging profits (EBITDA) and robust revenue growth.

Appen interim results in focus Source: Bloomberg

Updated price action at a glance

Though the Appen Limited share price rose significantly at the open, as is reflected in our headline, it has since tumbled more than 12%.

Even so, Appen's FY19 results delivered strong growth across the board, as the company saw upticks in revenue, a surge in earnings (EBITDA) and improved margins.

Much enthusiasm had been built leading into today’s release, with Appen’s share price rising 10.7% yesterday.

This bullish sentiment remained intact at the open but crumbled soon after: as the company initially saw its share price surge another 9.24% – to A$29.90 per share.

By comparison and as of 15:20 AEST, Appen (ASX: APX) traded at just A$24.40 per share.

1H19 results summarised

Appen Limited continues to demonstrate the importance of innovation when it comes to driving growth in the ultra-competitive tech space.

Off the back of this innovation, Appen (ASX: APX) saw its revenue top A$245.1m in 1H19.

Underlying earnings (EBITDA) also rose, reaching A$46.3m – representing an 81% increase, on a year-over-year basis.

Net income also grew in the 2019 first-half, hitting A$18.6m.

Management commentary on the results

Appen’s CEO, Mark Brayan, noted that the company’s strong 2019 first-half results demonstrates the significant potential of the fast-growing AI market.

Highlighting some of the key positives from these results, Mr Brayan said that 'speech and image data grew by 85% on the first half of last year, relevance revenue by 48%, and underlying EBITDA margins expanded from 16.8% to 18.9%.’

Margins benefited from increased scale and efficiency improvements, according to management.

With momentum often being the name of the game in tech, investors will likely also be pleased to hear that demand for Appen’s product offerings remains robust.

Here, Mr Brayan said that in the first-half the company witnessed, 'an increase in use cases and our existing customers are asking for more data to develop new AI products and to improve their existing offerings.'

Figure 8 acquisition in focus

Appen paid $175m up-front to acquire the AI company Figure 8 earlier in 2019. An additional payment of $125m may be paid in 2020, based on the company's FY19 performance.

Both figure 8 and Appen make use of a crowdsourced business model to build out machine learning and artificial intelligence capabilities.

Speaking of this acquisition, Appen noted that:

'The number and size of joint opportunities is exceeding our expectations, its technology, including its secure SOC 23 accreditation, is better than we first thought.’

Appen’s 2019 full-year guidance

Building on these strong results, Appen Limited’s management has forecasted that underlying FY19 EBITDA will come in at the higher end of the previous A$85m to A$90m guidance.

By comparison, Appen reported pro-forma earnings (EBITDA) of 71.3m in FY18.

Finally, the company, though pursuing an aggressive growth program still announced an interim dividend of A$0.04 per share.

Investors are likely to pay little heed to such a dividend given the market-beating returns Appen (ASX: APX) has delivered since January.

Year-to-date, Appen’s share price has risen 86% – far outpacing the ASX 200 index.

Click here now to read our report on Afterpay’s FY19 earnings, this week’s other big tech result.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.